Modified Xiehuangsan Regulates Microglial Polarization and TLR4/MyD88/NF-κB Pathway to Treat Tic Disorders in Rats
|更新时间:2025-01-16
|
Modified Xiehuangsan Regulates Microglial Polarization and TLR4/MyD88/NF-κB Pathway to Treat Tic Disorders in Rats
增强出版
“The latest research has found that Jiawei Xiehuang San can effectively improve neuroinflammation in rats with tic disorders by regulating microglial polarization and the TLR4/MyD88/NF - κ B signaling pathway.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 31, Issue 4, Pages: 10-18(2025)
ZHAO MENGJIE, ZHAO QIONG, YANG CUILING, et al. Modified Xiehuangsan Regulates Microglial Polarization and TLR4/MyD88/NF-κB Pathway to Treat Tic Disorders in Rats. [J]. Chinese journal of experimental traditional medical formulae, 2025, 31(4): 10-18.
DOI:
ZHAO MENGJIE, ZHAO QIONG, YANG CUILING, et al. Modified Xiehuangsan Regulates Microglial Polarization and TLR4/MyD88/NF-κB Pathway to Treat Tic Disorders in Rats. [J]. Chinese journal of experimental traditional medical formulae, 2025, 31(4): 10-18. DOI: 10.13422/j.cnki.syfjx.20241903.
Modified Xiehuangsan Regulates Microglial Polarization and TLR4/MyD88/NF-κB Pathway to Treat Tic Disorders in Rats增强出版